Cleared Traditional

Myocardial Strain Software Application (K232661) - FDA 510(k) Clearance

Class II Radiology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K232661 · Circle Cardiovascular Imaging · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2023
Decision
98d
Days
Class 2
Risk

K232661 is an FDA 510(k) clearance for the Myocardial Strain Software Application. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Circle Cardiovascular Imaging (Calgary, CA). The FDA issued a Cleared decision on December 7, 2023 after a review of 98 days - within the typical 510(k) review window.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all Circle Cardiovascular Imaging devices

Submission Details

510(k) Number K232661 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 31, 2023
Decision Date December 07, 2023
Days to Decision 98 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
9d faster than avg
Panel avg: 107d · This submission: 98d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 797
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K232661.
StrokeViewer Perfusion
K231570 · Nico-Lab B.V. · Dec 2023
TeleScan
K233634 · Bb Imaging · Dec 2023
DTX Studio Clinic (4.0)
K231898 · Nobel Biocare AB · Dec 2023
TraumaCad Neo
K231498 · Brainlab , Ltd. · Nov 2023
BrainSpec Core™ Software
K230856 · Brainspec, Inc. · Nov 2023
SwiftMR
K230854 · Airs Medical, Inc. · Oct 2023